Bio-identical Hormone & Peptide Specialists

Table of Contents
Cardio Res-Q Assessment from $775

Advanced labs, the Cleveland Heart panel and Dr. Varano’s evaluation:

Which Heart Tests Are Worth Having if Heart Disease Runs in Your Family

Which Heart Tests Are Worth Having if Heart Disease Runs in Your Family

If a parent, brother or sister had a heart attack, stent, bypass or stroke at a young age, a few tests add real information beyond a routine checkup. The short list is Lp(a) measured once, ApoB, the standard risk factors done properly, and for some people a coronary calcium score.

The aim is to find out what, if anything, you inherited, and whether plaque has already started. Most people with a family history do not need every heart test on offer. They need the right four or five, at the right age.

Key takeaways

  • With an early family history, the tests that add the most are Lp(a) once, ApoB, the standard risk factors and sometimes a calcium score.
  • You probably do not need every heart test available, just the right few at the right age.
  • A calcium scan done too young is usually zero, and a zero is less reassuring with a strong family history.
  • An untreated LDL of 190 mg/dL or higher is a reason to ask your doctor about familial hypercholesterolemia.
  • When an inherited cause is found, it matters for close relatives, who can be tested step by step.

First, does your family history count as early?

US cholesterol guidance defines a premature family history as heart or vascular disease in a first-degree male relative before 55 or a first-degree female relative before 65.1 First-degree means a parent, sibling or child.

A grandparent who had a heart attack at 80 is not in this category. A father who had one at 52 is. Our article on family history of early heart disease covers how much it raises your own risk. This one is about which tests to have.

Lp(a): once in your life

Lipoprotein(a), written Lp(a), is a cholesterol-carrying particle whose level is largely inherited. It does not show on a standard cholesterol panel. The 2026 US dyslipidemia guideline recommends measuring it once in all adults, and a family history of early heart disease is one of the clearest reasons not to put it off.2

Family history and Lp(a) each carry their own information. In a study of more than 12,000 adults followed for 21 years, a family history of heart disease and a high Lp(a) were each independently linked to cardiovascular events, and people with both had the highest risk.3

A level of 125 nmol/L (50 mg/dL) or more is listed in US guidance as a risk enhancer. There is no approved medicine that specifically lowers Lp(a), so a high result is used to guide how firmly your other risk factors are managed. Our Lp(a) test guide has the details.

ApoB and the standard risk factors

ApoB counts the particles that carry cholesterol into the artery wall. It can be high when LDL cholesterol looks acceptable, which is one way families with "normal cholesterol" still end up with early heart disease.

A national lipid expert group concluded that ApoB reflects the plaque-causing particle burden more accurately than LDL cholesterol, and that when the two disagree, risk generally tracks ApoB. An ApoB of 130 mg/dL or higher is listed in US guidance as a risk enhancer. See our ApoB guide for how to read your number.

The standard checks still matter most, done properly:

  • Blood pressure, measured more than once
  • A fasting lipid panel
  • Fasting glucose and A1c, and fasting insulin where insulin resistance is suspected
  • Smoking history, weight and waist size
  • hs-CRP as a marker of inflammation, which US guidance also counts as a risk enhancer at 2.0 mg/L or above

When imaging adds information

A coronary calcium score shows whether calcified plaque has actually formed. Timing matters, because a scan done too young is usually zero. A modeling study of more than 22,000 adults aged 30 to 50 estimated that a first scan becomes worthwhile at about 42 in men and 58 in women with no risk factors. A family history of heart disease was linked to calcium appearing roughly three to four years earlier.4

That puts a reasonable first scan around 40 for many men with a family history and in the mid 50s for many women, sooner if other risk factors are present. These are estimates from one study, not rules. The decision belongs with a clinician who knows your history.

Two cautions. A score of zero is reassuring, but US guidance treats it as less reassuring in people with a strong family history, as well as in people who smoke or have diabetes.2 And a carotid CIMT ultrasound adds less: US guidance does not recommend it for routine risk prediction.

Familial hypercholesterolemia and testing relatives

Familial hypercholesterolemia, or FH, is a specific inherited condition that causes very high LDL cholesterol from birth. It affects about 1 in 311 people worldwide and remains severely underdiagnosed.5

The main flag is an untreated LDL cholesterol of 190 mg/dL or higher, especially together with early heart disease in the family. Not everyone at that level has FH. In a large genetic study, fewer than 2% of people with LDL of 190 or above carried an FH gene variant.6 But those who did had about a 22-fold higher risk of coronary disease than people with LDL below 130 and no variant, compared with a 6-fold higher risk in people with the same high LDL and no variant.

If your LDL has ever been that high, raise FH with your doctor.

When an inherited cause is found, it matters to your family too. Cascade screening means testing close relatives step by step, starting with parents, siblings and children.

A 2026 expert consensus from the National Lipid Association recommends systematic cascade screening in families with FH. The same reasoning applies to Lp(a), because it is inherited too.

Choosing a Cardio Res-Q assessment with a family history

The Comprehensive Assessment ($775) covers the blood tests discussed here: ApoB, Lp(a), hs-CRP, homocysteine, insulin, glucose and A1c, plus the Cleveland Heart cardiac panel, a family history review and Dr. Varano's clinical evaluation. Lp(a) is measured once as an inherited baseline. The Enhanced Assessment ($999) adds a coronary calcium score and a CIMT ultrasound.

Which one fits depends mostly on your age and whether a calcium score would change your plan. Read Comprehensive vs. Enhanced: which to choose, then book through the Cardio Res-Q program page. Genetic testing for FH is not listed in either assessment, so ask our team if that is what you need.

Cardiovascular Risk Screener

Are You a Candidate for Cardio Res-Q?

Three quick questions about the risk factors we screen for. Your answers stay between you and the clinic.

Frequently asked questions

My father had a heart attack at 50. At what age should I be tested?

Blood tests such as a lipid panel, ApoB and Lp(a) can be done at any adult age, and earlier is better because they show what you inherited. A calcium score is usually more informative from around 40 in men and later in women, since younger scans are mostly zero.

Do I need a genetic test?

Not usually. Genetic testing is mainly considered when familial hypercholesterolemia is suspected, for example with an untreated LDL cholesterol of 190 mg/dL or more. Lp(a) is inherited, but it is measured with an ordinary blood test.

My calcium score is zero but heart disease runs in my family. Am I safe?

A zero is good news for the next several years, but guidance treats it as less reassuring when there is a strong family history. Keep managing risk factors, and ask your clinician when a repeat scan would make sense.

Related reading

This article is for general education and is not medical advice. Decisions about testing and medication should be made with your clinician. If you have chest pain or other symptoms of a heart attack, call 911.

Optimize Your Health Today!

Cardio Res-Q starts with the $775 Comprehensive or $999 Enhanced Assessment, led by Dr. Varano.

age management doctor philadelphia
Send Us A Message
About Dr. Kenneth Varano, D.O.
age management doctor philadelphia

YoungerMeMD is a physician-led practice in Anti-Aging, Functional and Preventive Medicine, and your care is delivered by our whole clinical team. That team works under Medical Director Kenneth Varano, D.O., who brings over 30 years in clinical medicine and more than 20 years in age management and functional medicine — using science-backed, patient-focused strategies that restore balance, vitality, and health longevity.

About Barbara Dougherty
anti aging treatments

Barbara Dougherty, MSN, CRNP, is a Board-Certified Family Nurse Practitioner and Certified Menopause Practitioner (MSCP) specializing in optimizing hormones, and improving cardio-metabolic health. 

Read Our Reviews

“I’ve been seeing Dr. Varano for just over a year now, and I don’t think I’ve been this healthy and energetic since grade school.

Transform Your Health Today

Ready to take the first step toward renewed energy, balance, and longevity? New patients can register for an initial evaluation to begin their personalized anti-aging journey with YoungerMe MD. Live Younger. Better. Longer. — with YoungerMe MD.

References

  1. Grundy SM, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 2019. PMID 30586774 · doi:10.1161/CIR.0000000000000625↩
  2. Blumenthal RS, et al. 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 2026. PMID 41824552 · doi:10.1161/CIR.0000000000001423↩
  3. Mehta A, et al. Lipoprotein(a) and Family History Predict Cardiovascular Disease Risk. J Am Coll Cardiol 2020. PMID 32792075 · doi:10.1016/j.jacc.2020.06.040↩
  4. Dzaye O, et al. Modeling the Recommended Age for Initiating Coronary Artery Calcium Testing Among At-Risk Young Adults. J Am Coll Cardiol 2021. PMID 34649694 · doi:10.1016/j.jacc.2021.08.019↩
  5. Ahmad Z, et al. Update on familial hypercholesterolemia: An expert clinical consensus from the National Lipid Association. J Clin Lipidol 2026. PMID 41741298 · doi:10.1016/j.jacl.2026.01.011↩
  6. Khera AV, et al. Diagnostic Yield and Clinical Utility of Sequencing Familial Hypercholesterolemia Genes in Patients With Severe Hypercholesterolemia. J Am Coll Cardiol 2016. PMID 27050191 · doi:10.1016/j.jacc.2016.03.520↩
Book a Discovery Call Peptide Consult
Close
Book a Discovery Call
Close
Peptide Consult







    Transform Your
    Health & Wellness

    Fill up the form below to get started

      Provocation agent administered prior to timed urine collection (<6hr). Reveals toxic metal burden that can block hormone and peptide response.

      Identifies gluten sensitivity, intestinal permeability (leaky gut), and wheat-related immune reactivity – distinct from standard celiac testing.

      DNA Based stool test detecting pathogens, bacterial imbalances, parasites, and digestive markers – a comprehensive gut microbiome assessment.

      Non-invasive carotid artery ultrasound measuring arterial wall thickness – a direct look at your cardiovascular age.

      Cardio Res-Q cardiac risk panel – inflammation markers and cardiovascular biomarkers beyond standard labs.

      Evaluates intracellular vitamin, mineral, and antioxidant status – foundational to optimizing cellular health and peptide efficacy.

      Full Sex hormone, thyroid and adrenal picture. Identifies imbalances that affect energy, recovery, cognition, and peptide response.

      Advanced testing for immune reactions to wheat, gluten, and intestinal permeability.

      What It Evaluates

      Heavy metals like mercury, lead, cadmium, arsenic, and aluminum can cause:

      Conditions We Identify